48,783 Shares in ZimVie Inc. (NASDAQ:ZIMV) Bought by Prudential Financial Inc.

Prudential Financial Inc. bought a new position in ZimVie Inc. (NASDAQ:ZIMV - Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm bought 48,783 shares of the company's stock, valued at approximately $681,000. Prudential Financial Inc. owned 0.18% of ZimVie as of its most recent SEC filing.

Several other institutional investors and hedge funds have also made changes to their positions in the business. SG Americas Securities LLC grew its stake in ZimVie by 15.7% in the fourth quarter. SG Americas Securities LLC now owns 11,110 shares of the company's stock worth $155,000 after purchasing an additional 1,508 shares in the last quarter. EMC Capital Management lifted its holdings in shares of ZimVie by 47.0% in the 4th quarter. EMC Capital Management now owns 13,802 shares of the company's stock worth $193,000 after buying an additional 4,414 shares during the period. Principal Financial Group Inc. bought a new position in shares of ZimVie during the 3rd quarter worth $275,000. Bailard Inc. grew its position in shares of ZimVie by 35.0% during the 4th quarter. Bailard Inc. now owns 21,194 shares of the company's stock worth $296,000 after buying an additional 5,494 shares in the last quarter. Finally, Fox Run Management L.L.C. purchased a new position in shares of ZimVie during the fourth quarter valued at $463,000. 95.63% of the stock is currently owned by institutional investors.

ZimVie Stock Up 0.9 %

Shares of NASDAQ:ZIMV traded up $0.08 on Friday, reaching $9.15. The company had a trading volume of 123,759 shares, compared to its average volume of 226,399. The firm has a market capitalization of $254.80 million, a PE ratio of -0.70 and a beta of 2.14. The company has a current ratio of 1.94, a quick ratio of 1.38 and a debt-to-equity ratio of 0.57. ZimVie Inc. has a 52-week low of $8.56 and a 52-week high of $22.40. The firm's 50 day simple moving average is $11.97 and its 200-day simple moving average is $13.48.

ZimVie (NASDAQ:ZIMV - Get Free Report) last posted its earnings results on Wednesday, February 26th. The company reported $0.27 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.25 by $0.02. The company had revenue of $111.52 million for the quarter, compared to analyst estimates of $113.67 million. ZimVie had a positive return on equity of 2.90% and a negative net margin of 77.31%. As a group, analysts expect that ZimVie Inc. will post 0.6 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

A number of research firms recently weighed in on ZIMV. Needham & Company LLC reaffirmed a "hold" rating on shares of ZimVie in a research note on Wednesday. B. Riley initiated coverage on shares of ZimVie in a research report on Thursday. They issued a "buy" rating and a $16.00 price target for the company.

About ZimVie

ZimVie Inc, together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It operates through two segments, The Dental Segment and The Spine Segment.